Cosmos Health INC 10-Q quarterly reports

Cosmos Health Inc. reported a significant increase in revenue for Q3 and the nine months ended September 30, 2025, driven by strategic expansions and acquisitions, though net losses widened due to substantial non-cash charges and increased financing costs.

Cosmos Health Inc. reported increased revenue and gross profit for Q2 2025, alongside a reduced net loss, but acknowledged persistent substantial doubt about its ability to continue as a going concern despite securing a new $300 million convertible note facility.

Cosmos Health Inc.'s Q1 2025 results show a slight revenue decrease but a significant reduction in net loss, driven by a shift towards higher-margin product lines and cost management efforts.

Cosmos Health Inc. reported its third quarter 2024 results, showing a slight decrease in revenue compared to the same period last year, while also expressing substantial doubt about its ability to continue as a going concern.

Cosmos Health Inc. reports a 12.45% increase in revenue year-over-year for the six months ended June 30, 2024, while also noting a net loss of $4.45 million.

Cosmos Health Inc. saw a revenue increase in the first quarter of 2024, but also experienced a larger net loss compared to the same period last year.